Welcome to Paid Research Studies




  • Conditions:   Low Back Pain;   Pain
    Interventions:   Drug: D-cycloserine;   Drug: Placebo
    Sponsors:   Northwestern University;   United States Department of Defense
    Recruiting

  • Condition:   Gulf War Illness
    Interventions:   Drug: D-cycloserine;   Drug: Placebos
    Sponsor:   Boston University Charles River Campus
    Recruiting

  • Condition:   Posttraumatic Stress Disorder
    Interventions:   Drug: DCS;   Other: Placebo
    Sponsor:   Weill Medical College of Cornell University
    Recruiting

  • Condition:   PTSD
    Interventions:   Behavioral: CBT + ImRs;   Behavioral: CBT + I.E.;   Drug: D-Cycloserine;   Drug: Placebo;   Drug: Study Pill
    Sponsors:   Boston University Charles River Campus;   James S McDonnell Foundation
    Recruiting

  • Condition:   Spinal Cord Injury
    Interventions:   Drug: D-Cycloserine;   Drug: Placebo;   Other: Training;   Other: Stimulation;   Other: Placebo Stimulation
    Sponsors:   University of Miami;   The Craig H. Neilsen Foundation
    Recruiting

  • Condition:   Spinal Cord Injury
    Interventions:   Drug: Seromycin;   Device: STDP;   Other: Training;   Drug: Dextromethorphan;   Drug: Seromycin Placebo;   Drug: Dextromethorphan Placebo;   Device: Sham STDP
    Sponsors:   VA Office of Research and Development;   University of Miami
    Recruiting

  • Condition:   SCI
    Interventions:   Behavioral: hypoxia;   Behavioral: sham hypoxia;   Drug: D-cycloserine;   Drug: sham-NMDA agonist;   Behavioral: exercise training
    Sponsor:   VA Office of Research and Development
    Not yet recruiting

  • Conditions:   Bipolar Depression;   Suicidal Ideation
    Interventions:   Drug: NRX-101;   Drug: Lurasidone HCl
    Sponsors:   NeuroRx, Inc.;   Target Health Inc.;   Bracket, Inc.;   Statistics Collaborative, Inc.
    Not yet recruiting

  • Conditions:   Bipolar Depression;   Suicidal Ideation
    Interventions:   Drug: NRX-101;   Drug: Lurasidone HCl;   Drug: Placebo
    Sponsors:   NeuroRx, Inc.;   Target Health Inc.
    Recruiting

  • Condition:   HIV Infections
    Interventions:   Drug: atazanavir/cobicistat;   Drug: darunavir/ritonavir;   Drug: darunavir/cobicistat;   Drug: etravirine;   Drug: elvitegravir/cobicistat;   Drug: dolutegravir;   Drug: tenofovir alafenamide fumarate (TAF);   Drug: TAF/cobicistat;   Drug: TAF/ritonavir;   Drug: efavirenz;   Drug: lopinavir/ritonavir;   Drug: nevirapine;   Drug: rifampicin;   Drug: ethambutol;   Drug: isoniazid;   Drug: pyrazinamide;   Drug: kanamycin;   Drug: amikacin;   Drug: capreomycin;   Drug: moxifloxacin;   Drug: levofloxacin;   Drug: ofloxacin;   Drug: ethionamide/prothionamide;   Drug: terizidone/cycloserine;   Drug: para-aminosalicylic acid (PAS);   Drug: high dose isoniazid (INH);   Drug: bedaquiline;   Drug: clofazamine;   Drug: delamanid;   Drug: linezolid;   Drug: pretomanid;   Drug: atazanavir/ritonavir/tenofovir;   Drug: ethinyl estradiol oral contraceptive;   Drug: etonogestrel implant
    Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting